Skip to content
Medical Health Aged Care, Research Development

ANZGOG Announces Keynote Speaker for 2025 Annual Scientific Meeting: A/Professor Carien Creutzberg

Australia New Zealand Gynaecological Oncology Group (ANZGOG) 2 mins read

The Australia New Zealand Gynaecological Oncology Group (ANZGOG) is pleased to welcome internationally renowned Radiation Oncologist Professor Carien Creutzberg as a keynote speaker at the 2024 ANZGOG Annual Scientific Meeting (ASM), taking place in Canberra from 5-7 March 2025. 

Professor Creutzberg, a distinguished expert in gynaecological cancers from Leiden University Medical Center, Netherlands, has dedicated more than three decades to advancing clinical research and improving treatment outcomes for patients with gynaecological malignancies. As the chief investigator of the internationally recognised PORTEC trials on endometrial cancer, her groundbreaking research has shaped global treatment guidelines and continues to drive advancements in personalised cancer care. 

Her leadership extends beyond research, as a co-founder of the Dutch Gynaecological Oncology Group and the TransPORTEC Consortium, which has significantly enhanced molecular understanding of endometrial cancer. In recognition of her outstanding contributions to the field, Professor Creutzberg was awarded the International Gynecologic Cancer Society (IGCS) Lifetime Achievement Award. 

ANZGOG’s ASM brings together national and international experts in gynaecological medicine, radiation and surgical oncology, pathology, basic scientists, translational and quality of life researchers, study coordinators and nurses, as well as our partners in the pharmaceutical industry. The meeting enables attendees to learn about the latest developments in gynaecological cancer and provides education and capacity-building opportunities amongst members and industry personnel, making it an essential event for anyone involved in gynaecological cancers.   

Don’t miss out on this unique opportunity to hear from one of the world’s leading experts in gynaecological oncology. For more information and to register, visit www.anzgogasm.org.au. #ANZGOG2025ASM - ENDS 


About us:

About ANZGOG: The Australia New Zealand Gynaecological Oncology Group (ANZGOG) is the peak national gynaecological cancer research organisation for Australia and New Zealand. Our mission is to improve outcomes and quality of life for everyone with a lived experience of gynaecological cancer by conducting and promoting clinical trials and multidisciplinary research.​ 


Contact details:

Media Contact:  

Monique Cerreto, ANZGOG Head of Communications & Engagement 

E: [email protected]  P: +61 0416 282 464

Media

More from this category

  • Engineering, Medical Health Aged Care
  • 17/12/2025
  • 09:02
UNSW Sydney

UNSW students claim victory in international artificial heart competition

A team of undergraduate engineering students from UNSW Sydney has claimed first place at a prestigious international artificial heart design competition in Vienna. The…

  • Contains:
  • Medical Health Aged Care, Science
  • 17/12/2025
  • 07:56
Australian and New Zealand Journal of Public Health

Summer Mozzie Warning – Ross River Virus risk linked to warmer temperatures

17 December 2025 - Australians are being urged to prevent mosquito bites this summer, after research mapping studies from across the country found that warmer temperatures heighten the risk of Ross River Virus outbreaks, especially inriverland and coastal regions. The scoping review, led by the University of Adelaide, and published today in the Australian and New Zealand Journal of Public Health, also uncovered a knowledge gap when it comes to understanding the impact of temperature on Ross River Virus notifications within inland Australia. Ross River Virus is a common mosquito-borne diseases in Australia, with around 3,000 cases reported annually. It…

  • CharitiesAidWelfare, Medical Health Aged Care
  • 17/12/2025
  • 06:00
Leukaemia Foundation

Leukaemia Foundation welcomes South Australian Government commitment to establish dedicated CAR T therapy service

The Leukaemia Foundation has welcomed the announcement by theMalinauskas Labor Government that South Australia is establishing a dedicated CAR T-cell therapy service as a line of treatment for people living with blood cancer – marking a major advancement in cancer care in the State. The new service, expected to commence by mid-2026, will significantly improve access to this highly specialised, life-saving treatment and reduce the need for South Australians to travel interstate for care. Leukaemia Foundation Chief Executive Officer Chris Tanti said the announcement represented a huge win for blood cancer patients and their families. “This is a landmark step…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.